KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Long-Term Investments (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Long-Term Investments for 12 consecutive years, with $136.0 million as the latest value for Q4 2025.

  • Quarterly Long-Term Investments rose 10.57% to $136.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $136.0 million through Dec 2025, up 10.57% year-over-year, with the annual reading at $136.0 million for FY2025, 10.57% up from the prior year.
  • Long-Term Investments hit $136.0 million in Q4 2025 for Quest Diagnostics, down from $137.0 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $527.0 million in Q1 2021 to a low of $111.0 million in Q2 2021.
  • Historically, Long-Term Investments has averaged $152.6 million across 5 years, with a median of $134.5 million in 2023.
  • Biggest five-year swings in Long-Term Investments: crashed 77.58% in 2021 and later skyrocketed 32.43% in 2022.
  • Year by year, Long-Term Investments stood at $141.0 million in 2021, then decreased by 6.38% to $132.0 million in 2022, then rose by 2.27% to $135.0 million in 2023, then fell by 8.89% to $123.0 million in 2024, then rose by 10.57% to $136.0 million in 2025.
  • Business Quant data shows Long-Term Investments for DGX at $136.0 million in Q4 2025, $137.0 million in Q3 2025, and $136.0 million in Q2 2025.